Mechanism Capital’s Andrew Kang said DeSci protocols will likely change their existing models before evolving into more market-ready products.

DeSci, Healthcare, Andrew Kang, Mechanism Capital, BIO Protocol, Pump Science, GLP1, OriginTrailRead More

You might also be interested in reading WisdomTree’s Bitcoin ETF filing joins hopefuls vying for approval.